Cargando…

p53 Status Predicts the Efficacy of Postoperative Oral Administration of Tegafur for Completely Resected Non‐small Cell Lung Cancer

Although postoperative adjuvant therapy for non‐small cell lung cancer (NSCLC) had not been reported to be effective, it has been reported recently that oral administration of tegafur (1‐[2‐tetrahydrofuryl]‐5‐fluorouracil, FT) may improve the postoperative prognosis. In the present paper, to examine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Fumihiro, Yanagihara, Kazuhiro, Ohtake, Yohsuke, Miyahara, Ryou, Kawano, Youzou, Fukuse, Tatsuo, Hitomi, Shigeki, Wada, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926087/ https://www.ncbi.nlm.nih.gov/pubmed/10363582 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00766.x

Ejemplares similares

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Expression of Thymidylate Synthase in Human Non‐small Cell Lung Cancer
por: Otake, Yosuke, et al.
Publicado: (1999)

Administration Method of Adjuvant Tegafur‐Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study
por: Hata, Taishi, et al.
Publicado: (2021)

Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer
por: Watanabe, Toru
Publicado: (2013)

Tegafur-induced acral hyperpigmentation
por: Teixeira, Vera, et al.
Publicado: (2011)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Tegafur/gimeracil/oteracil‐induced eosinophilic pneumonia
por: Sumi, Toshiyuki, et al.
Publicado: (2020)

Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
por: Nishikubo, Megumi, et al.
Publicado: (2023)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report
por: Kawamoto, Nobutaka, et al.
Publicado: (2021)

Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours.
por: Oki, E., et al.
Publicado: (1998)

A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer
por: Kurihara, Minoru, et al.
Publicado: (1991)

An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer
por: Sakamoto, J, et al.
Publicado: (2007)

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02
por: Nakagawa, Masatsugu, et al.
Publicado: (2009)

Oral Tegafur/folinic acid chemotherapy decreases phenytoin efficacy
por: Veldhorst-Janssen, N M L, et al.
Publicado: (2004)

Tegafur-uracil-induced rapid development of advanced hepatic fibrosis
por: Honda, Shuya, et al.
Publicado: (2017)

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
por: Ward, S E, et al.
Publicado: (2006)

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
por: Almond, J, et al.
Publicado: (2007)

Tumor suppression by Tegafur combined with Barbadian in S-180 tumor-bearing mice
por: Zhang, Enning, et al.
Publicado: (2018)

Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients
por: Liang, Sheng‐Kai, et al.
Publicado: (2023)

How I Do It: Inferior Turbinectomy: Modified Techniques for Submucosal Resection
por: Omura, Kazuhiro, et al.
Publicado: (2021)

Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study
por: Kuo, Yi-Hung, et al.
Publicado: (2019)

Uracil-tegafur vs fluorouracil as postoperative adjuvant chemotherapy in Stage II and III colon cancer: A nationwide cohort study and meta-analysis
por: Chen, Po-Huang, et al.
Publicado: (2021)

Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer
por: Ward, S E
Publicado: (2007)

Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.
por: Palmeri, S., et al.
Publicado: (1990)

Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC—Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy
por: Shukuya, Takehito, et al.
Publicado: (2022)

Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension
por: Huang, Pei-Wei, et al.
Publicado: (2022)

Delayed mite hatching in response to mechanical stimuli simulating egg predation attempts
por: Fukuse, Kaoru, et al.
Publicado: (2019)

A Case of Diffuse Alveolar Hemorrhage Associated with Tegafur Plus Uracil and Warfarin Therapy
por: Itoh, Masayuki, et al.
Publicado: (2011)

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm
por: Peng, Mei, et al.
Publicado: (2015)

High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer
por: Sakaguchi, Isao, et al.
Publicado: (2015)

Feasibility of metronomic chemotherapy with tegafur-uracil, cisplatin, and dexamethasone for docetaxel-refractory prostate cancer
por: Kubota, Hiroki, et al.
Publicado: (2017)

Expression of CYP2A6 in Tumor Cells Augments Cellular Sensitivity to Tegafur
por: Murayama, Norie, et al.
Publicado: (2001)

Enantioselectivity in the cytochrome P450-dependent conversion of tegafur to 5-fluorouracil in human liver microsomes
por: Yamamiya, Ikuo, et al.
Publicado: (2013)

Metabolism of Tegafur in Rat Liver Observed by in vivo (19)F Magnetic Resonance Spectroscopy and Chromatography
por: Harada, Masafumi, et al.
Publicado: (1992)

Tegafur deteriorates established cardiovascular atherosclerosis in colon cancer: A case report and review of the literature
por: Zhang, Shi-Chang, et al.
Publicado: (2019)

Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer
por: Huang, Wen-Yen, et al.
Publicado: (2017)

Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis
por: Yen, Chih-Chieh, et al.
Publicado: (2021)

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)
por: Nakayama, Takahiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j3b1j2osfinjim5i966fr2sveo